NCT02123823 2025-07-15BI 836845 in Estrogen Receptor Positive Metastatic Breast CancerBoehringer IngelheimPhase 1 Completed164 enrolled 21 charts
NCT02077933 2020-12-08Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic TumorsNovartisPhase 1 Completed79 enrolled